South Korean Companies Invest in Indonesia’s Regenerative Medicine and Cell Therapy Market
South Korea’s Daewoong Pharmaceutical and GC Cell are entering Indonesia’s regenerative medicine and cell therapy markets. Daewoong Pharmaceutical has established a cell therapy and cosmetics production plant in Indonesia through its subsidiary, Daewoong...
South Korea’s Celltrion Establishes Subsidiary in Vietnam to Expand Biopharmaceutical Market
South Korea’s Celltrion has successfully set up a local subsidiary in Vietnam, a pivotal market within the ASEAN pharmaceutical landscape. The company aims to secure sales permits for its flagship products by the end of 2024 and distribute its treatments...
Insulet Opens New Manufacturing Facility Worth USD 200 Million in Malaysia
Insulet, a U.S.-based diabetes device manufacturer, has officially opened a new manufacturing facility in Johor Bahru, Malaysia, marking a significant milestone in a USD 200 million investment. Spanning 400,000 square feet, the new plant is twice the size of the...